The coconut oil can delay Alzheimer’s

News 16 March, 2018
  • Photo special collaboration, Caroline Lepage
    The search agent, Christian-Alexandre Castellano shows dietary supplements to coconut oil that are given to the participants of the study.

    Caroline Lepage

    Friday, 16 march, 2018 01:00

    UPDATE
    Friday, 16 march, 2018 01:00

    Look at this article

    SHERBROOKE | quebec researchers are on the point of concluding that the coconut oil purified may delay the onset of Alzheimer’s in people at risk of developing the disease.

    With age, many people, especially those who suffer from Alzheimer’s, difficulty to use the glucose, which acts as fuel to the brain.

    Photo courtesy

    Stephen Cunnane
    Researcher

    Since 2015, the researcher Stephen Cunnane directs the project “Benefic” at the research Centre on aging in Sherbrooke, which aims to resolve this problem

    A simple supplement

    The team found that a simple food supplement with a basis of coconut oil purified manages to bridge the deficit in glucose.

    For six months, 50 people 65 years and over with a slight memory problem had to drink a liquid, morning and evening. Twenty-five of them drank an emulsion of milk with coconut oil, and purified.

    “We chose this formula to avoid side effects,” explains the search agent, Christian-Alexandre Castellano.

    The other half of the group was eating, without knowing it, a liquid without the oil.

    At the end of the project, the rate of ketones, used as an energy source when reserves of sugars are insufficient, had doubled in participants who drank the supplement with the coconut oil, and purified.

    According to Mr. Castellano, the latter have also increased their attention, their memory and their speed of information processing.

    A big step

    The project is currently undertaking a second phase, with two times more participants, in order to draw firm conclusions.

    The researchers hope to succeed delay with a simple nutritional supplement the onset of Alzheimer’s disease in people at risk. They also want to contribute to the capacity of those already affected are declining less rapidly.